Programmable cells
Commercial scalingCells are engineered as production systems, sensors, and therapeutics.
Design-build-test loops are increasingly automated.
Company detail
Provides cloud software, AI workflows, and data systems for biotechnology research and development.
Related industries
Industries linked to the company's observed ecosystem role.
Related capabilities
Capabilities associated with the company's role in the research map.
Cells are engineered as production systems, sensors, and therapeutics.
Design-build-test loops are increasingly automated.
Fermentation and downstream processing determine unit economics.
More programs are reaching contract manufacturing and end markets.
Related milestones
Milestones that reference this company or institution.
Synthetic biology scale increasingly depends on data systems, ordering workflows, and AI-enabled analysis rather than wet-lab tools alone.
| Date | Milestone | Capability | Related | Evidence |
|---|---|---|---|---|
| May 12, 2026 | Benchling launches AI-enabled R&D products at SynBioBeta 2026Synthetic biology scale increasingly depends on data systems, ordering workflows, and AI-enabled analysis rather than wet-lab tools alone. |
Evidence
Evidence links connect company and industry claims to source-backed records.
Free API layer
Public APIs expand the research graph while preserving neutral analytical framing.